Oncogenic KRAS engages an RSK1/NF1 complex in pancreatic cancer
D. K. Cheng, T. E. Oni, Y. Park, J. S. Thalappillil, H.-c. Ting, N. Prasad, B. Alagesan, K. D. Rivera, D. J. Pappin, L. Van Aelst, D. A. Tuveson
This study identifies RSK1 as a KRASG12D-specific interactor in PDAC and shows RSK1 mediates negative feedback on wild-type KRAS.
bioRxiv · Sep 14, 2020 · PreprintCancer Biology